These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25367054)

  • 1. Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands.
    Schurink-Van't Klooster TM; de Ridder MA; Kemmeren JM; van der Lei J; Dekker F; Sturkenboom M; de Melker HE
    Eur J Pediatr; 2015 May; 174(5):641-9. PubMed ID: 25367054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    Yoon D; Lee JH; Lee H; Shin JY
    BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
    Schurink-Van't Klooster TM; Kemmeren JM; van der Maas NAT; van de Putte EM; Ter Wolbeek M; Nijhof SL; Vanrolleghem AM; van Vliet JA; Sturkenboom M; de Melker HE
    Vaccine; 2018 Oct; 36(45):6796-6802. PubMed ID: 30262246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
    Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
    JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
    Hoes J; Woestenberg PJ; Bogaards JA; King AJ; de Melker HE; Berkhof J; Hoebe CJPA; van der Sande MAB; van Benthem BHB;
    Clin Infect Dis; 2021 Mar; 72(5):e103-e111. PubMed ID: 33249475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands.
    Mollers M; Lubbers K; Spoelstra SK; Weijmar-Schultz WC; Daemen T; Westra TA; van der Sande MA; Nijman HW; de Melker HE; Tami A
    BMC Public Health; 2014 Mar; 14():288. PubMed ID: 24679163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events from HPV vaccination in Taiwan.
    Tsai SA; Lu CY; Chen TI; Huang SP; Chen YC
    Vaccine; 2023 Nov; 41(49):7444-7449. PubMed ID: 37949754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.
    Donken R; Tami A; Knol MJ; Lubbers K; van der Sande MAB; Nijman HW; Daemen T; Weijmar Schultz WCM; de Melker HE
    BMC Public Health; 2018 Jul; 18(1):837. PubMed ID: 29976170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
    Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.
    Bi D; Apter D; Eriksson T; Hokkanen M; Zima J; Damaso S; Soila M; Dubin G; Lehtinen M; Struyf F
    Hum Vaccin Immunother; 2020 Jun; 16(6):1392-1403. PubMed ID: 31829767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
    Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
    J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.
    Hviid A; Svanström H; Scheller NM; Grönlund O; Pasternak B; Arnheim-Dahlström L
    J Intern Med; 2018 Feb; 283(2):154-165. PubMed ID: 29044769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review.
    Meggiolaro A; Migliara G; La Torre G
    Hum Vaccin Immunother; 2018 May; 14(5):1266-1274. PubMed ID: 29333935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in England.
    Andrews N; Stowe J; Miller E
    Vaccine; 2017 Mar; 35(13):1729-1732. PubMed ID: 28245941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-Controlled Case Series, and Population Time Trend Studies.
    Thomsen RW; Öztürk B; Pedersen L; Nicolaisen SK; Petersen I; Olsen J; Sørensen HT
    Am J Epidemiol; 2020 Apr; 189(4):277-285. PubMed ID: 31899791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccination and all-cause morbidity in adolescent girls: a cohort study of absence from school due to illness.
    Hviid A; Thorsen NM; Thomsen LN; Møller FT; Wiwe A; Frisch M; Valentiner-Branth P; Rytter D; Mølbak K
    Int J Epidemiol; 2021 May; 50(2):518-526. PubMed ID: 33547468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
    Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
    JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.